Zaplakhova, O. V.,
Nasibullin, T. R.,
Tuktarova, I. A.,
Timasheva, Y. R.,
Erdman, V. V.,
Bakhtiyarova, K. Z.,
Mustafina, O. E. (2018) 1109670*C/A (p = 0.017, OR = 2.06). In addition, using the APSampler algorithm, we identified
combinations revealed 12 allele/genotype
combinations that remained significantly associated with essential hypertension
additional associations of the
combinations of the
studied loci with hypertension. Our results suggest
CONNORS, J.M.,
SAVAGE, K.J,
JURCZAK, W,
LECH-MARANDA, E.,
SMOLEWSKI, P,
WALEWSKI, J,
STRAUS, D.J.,
YOUNES, A.,
ANSELL, S.M.,
KIM, W.S.,
GALLAMINI, A.,
ALEKSEEV, S.,
ILLÉS, A.,
ROSTA, A.,
PICARDI, M.,
ZINZANI, P.L.,
OKI, Y.,
FELDMAN, T.,
BARTLETT, N.L.,
CHEN, R.,
RAMCHANDREN, R.,
CUNNINGHAM, D.,
RADFORD, J.,
JOSEPHSON, N.C.,
SONG, E.,
SACHS, J.,
JOLIN, H.A.,
HUEBNER, D.,
LIU, R.,
LIPATOV, O.N. (2018) lymphoma, with a 4.9 percentage-point lower
combined risk of progression,
death, or noncomplete response